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Background: Bone marrow transplantation (BMT) is commonly used in experimental studies to investigate the
contribution of BM-derived circulating cells to different disease processes. During studies investigating the cardi-
ac response to acute myocardial infarction (MI) induced by permanent coronary ligation inmice that had previ-
ously undergone BMT, we found that BMT itself affects the remodelling response.
Methods and results: Compared to matched naive mice, animals that had previously undergone BMT developed
signiﬁcantly less post-MI adverse remodelling, infarct thinning and contractile dysfunction as assessed by serial
magnetic resonance imaging. Cardiac rupture inmalemice was prevented. Histological analysis showed that the
infarcts of mice that had undergone BMT had a signiﬁcantly higher number of inﬂammatory cells, surviving
cardiomyocytes and neovessels than control mice, as well as evidence of signiﬁcant haemosiderin deposition.
Flow cytometric and histological analyses demonstrated a higher number of alternatively activated (M2)macro-
phages inmyocardium of the BMT group compared to control animals even beforeMI, and this increased further
in the infarcts of the BMT mice after MI.
Conclusions: The process of BMT itself substantially alters tissue macrophage phenotype and the subsequent re-
sponse to acuteMI. An increase in alternatively activatedmacrophages in this setting appears to enhance cardiac
recovery after MI.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Bonemarrow transplantation (BMT) is commonly used in experimen-
tal studies designed to investigate the speciﬁc contribution of BM-derived
circulating cells to disease processes. The method involves irradiation of
the recipient to ablate BM cells, followed by transplantation of donor
BM, typically via intravenous infusion [1,2]. In mice after syngeneic BM
transplantation, the BM, circulating and tissue pools of leukocytes are
generally reconstituted within 2–3 weeks [1,2]. The use of BMT to gener-
ate chimericmicewith different gene expression in BM-derived cells ver-
sus host cells is a powerful approach in cardiovascular diseases [3–6].
Acute myocardial infarction (MI) evokes an initial inﬂammatory re-
sponse involving inﬁltration by neutrophils, monocytes/macrophages
and lymphocytes, duringwhich the infarct undergoes repair and aﬁbrous
scar is laid down. This is followed by a phase of infarct scar maturation,
thinning and then gradual infarct expansion with adverse left ventricular
(LV) remodelling. The latter results in ventricular dilatation and reduction
in contractile function and involves signiﬁcant changes in the non-
infarctedmyocardium, such as cardiomyocyte hypertrophy, interstitial ﬁ-
brosis and other alterations in the extracellular matrix [7–9]. BMT in the
context of acute myocardial infarction (MI) has been valuable in demon-
strating the importance of macrophage-mediated inﬂammation [10,11]
or the roles of BM-derived progenitor cells [12] in post-MI cardiac remod-
elling and dysfunction.
In the course of a study investigating responses to acute MI in mice
that had undergone BMT, we found that the process of BMT itself sub-
stantially alters the response of the heart to acute MI. Here, we report
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that when acute MI is induced by permanent coronary ligation after
BMT, there is a signiﬁcantly enhanced cardiac contractile recovery and
a reduction in adverse remodelling that is attributable to an altered tis-
sue macrophage phenotype. This previously unrecognised effect may
signiﬁcant alter interpretation of studies involving BMT and MI and
also provides new insights into the role of inﬂammatory cells in cardiac
repair after MI.
2. Methods
Animal studies were conducted in accordance with the Guidance on
the Operation of the Animals (Scientiﬁc Procedures) Act, 1986 (UK
Home Ofﬁce) and institutional guidelines. Studies were performed on
C57BL/6 mice. The experimental protocol is shown in Supplementary
Fig. 1.
2.1. BMT
BMT was performed using standard methods [13]. Mice aged 8–
11 weeks were irradiated with a lethal dose of 9 Gy (9000 mSv). At
24h, BM isolated fromdonorC57BL/6micewas injected into the recipient
via the tail vein at a dose of 9 × 107 cells in 200 μl. Brieﬂy, donor BMwas
harvested in DMEM, ﬁltered through a 40 μm cell strainer, washed in
fresh DMEM, and then re-suspended in PBS at a ﬁnal concentration of
4.5 × 108/ml. Animals were allowed to recover for 4 weeks. Female
mice were used for most experiments. Survival was assessed in both
male and female C57BL/6 mice.
2.2. Induction of MI
Permanent left coronary artery ligation was performed as described
previously [14]. Animals were anaesthetised with 2% isoﬂurane/98% oxy-
gen and ventilated via endotracheal intubation. A lateral thoracotomy
was made in the fourth intercostal space. The pericardium was removed
and the left coronary artery was ligated 1–2 mm below the tip of the left
atrium. The chestwallwas repaired in layers.Micewere allowed to recover
in a warmed chamber for at least 6 h and treated with intramuscular
buprenorphine and subcutaneous ﬂunixin for perioperative analgaesia.
2.3. Cardiac magnetic resonance imaging (CMRI)
CMRI was performed at 3, 10 and 21 days after surgery on a 7T hori-
zontal scanner (Agilent, Varian Inc., Palo Alto, CA). The gradient coil had
an inner diameter of 12 cm, gradient strength of 1000 mT/m (100 G/
cm) and rise-time of 120 μs. A quadrature transmit/receive coil (RAPID
Biomedical GmbH, Germany) with an internal diameter of 39 mm was
used. Anaesthesia was maintained with 1.5% isoﬂurane and a mix of O2/
medical air. Body temperature was maintained at 37° using a warm air
fan. The ECG was monitored via two metallic electrodes placed subcuta-
neously in the front paws. A pressure-transducer for respiratory gating
was placed on the abdomen. Simultaneous ECG triggering and respiration
gating (SA Instruments) was applied.
The CMRI protocol included (a) T1-weighted acquisition of functional/
volumetric and anatomical parameters [15]; (b) T1-weighted acquisition
for late gadolinium enhancement (LGE) after intraperitoneal (i.p.) injec-
tion of 0.75 mmol/kg of gadolinium DPTA (Magnevist, Schering
Healthcare, UK) [15]; and (c) T2*-weighted acquisition for haemosiderin
localisation and T2* evaluation. LGE scans were performed 20–30 min
post-injection on day 3 post-MI to evaluate the infarcted area. Heart
rates ranged from400 to 500 bpm (cycle length 120–150ms)with a ﬂuc-
tuation of ±10 ms per cardiac cycle.
Cine-FLASH was used as a T1-weighted method for temporally
resolved dynamic short-axis cardiac images to quantify functional/
volumetric parameters and LGE acquisitions. Imaging parameters
were: repetition time (TR) = 1 RR-interval/number of frames (typi-
cally ~9–10 ms), effective repetition time (TReff) = RR-interval,
echo time (TE) = 1 ms, ﬁeld of view (FOV) = 25 × 25 mm, matrix
size = 128 × 128, slice thickness = 1 mm; ﬂip angle =40°, 3 aver-
ages, 9–11 slices, 1 k-space line/frame, 9–12 frames equally distrib-
uted along the cardiac cycle. The acquisition time was 8 ± 0.5 min.
Triggering was positioned at the peak of the QRS complex. Single
ECG gating was used to maintain a steady-state during acquisition
in T1 weighted scans.
Cine-FLASH was also used as a T2*-weighted method to locate areas
of signal void and the related T2* value. Imaging parameters were:
TR = 3 RR-intervals (≈400 ms); TE = 1, 2, 3, 5, 7 ms; single frame ac-
quired, typically the diastolic frame; FOV = 25 × 25 mm2; matrix
size = 128 × 128; slice thickness = 1 mm; number of slices = 5; ﬂip
angle= 40°; 3 averages; scanning time= 12± 0.5min. ECG and respi-
ration triggeringwere used, although, during respiration, signal acquisi-
tion and RF pulses were turned off. The trigger was positioned at the
peak of the QRS complex corresponding to the diastolic phase.
T2* valueswere achieved by applying a T2* ﬁt to themulti-echo T2*-
weighted cine-FLASH images (TE varying from 1 to 7 ms) using ImageJ
(NIH, Bethesda, MD). The T2* ﬁtted followed the following equation:
S= S0 exp.(−TEn/T2*).
where S0 is the signal at fullmagnetisation, TE is the echo time and n
identiﬁes the echo time under study. Areas of rapid signal decay,
affected by strong susceptibility effects, were compared to the control
infarcted myocardium where a drop in signal was much less severe.
LV ejection fraction (EF), LV end-diastolic volume (LVEDV), LV end-
systolic volume (LVESV) and LV mass were obtained from cine-FLASH
T1-weighted images [16] using custom segmentation analysis software
(www.clinicalvolumes.com). The initial infarct area (as a percentage of
the LV) was analysed from cine-FLASH LGE images 3 days post-MI [15].
On subsequent scans, the extension of the infarct through the LV was
quantiﬁed using a mid-line method [17]. The wall thickness along in-
farcted regionswas evaluated bymeasuring the endocardium to epicar-
dium distance using ImageJ software (NIH, Bethesda, MD) on the
middle slice of CMRI images at 21 days post-MI.
2.4. Histology and immunostaining
Hearts were harvested and immediately immersed in 10% formalin
for 48 h at 4 °C. Hearts were then embedded in parafﬁn and sectioned
in 5 μm-thick transverse slices. After deparafﬁnisation and rehydration,
sections were stained with haematoxylin-eosin (H&E), Prussian blue
and Picrosirius red.
Cardiomyocytes were stained with an anti-troponin I antibody
(Abcam, Cambridge, UK). The thickness of the infarct was evaluated in
representative slices taken in the middle of the heart by measuring the
endocardium to epicardiumdistance using ImageJ software (NIH, Bethes-
da, MD). Rhodamine-conjugated wheat germ agglutinin (WGA) was
used to outline cell membranes. Large vessels and capillaries were
labelled with anti-sm22α and isolectin B4 antibodies, respectively. Leu-
kocytes were labelled using an anti-CD45 antibody (BD Biosciences,
USA), detected with an HRP/DAB system followed by haematoxylin
counterstaining. A similar procedure was used to detect CD163 (Bioss
Inc., USA), a receptor involved in clearance and endocytosis of
haemoglobin/haptoglobin complexes bymacrophages [18], andVCAM-1.
Imaging was performed on an Olympus IX-81 microscope. Quantiﬁ-
cation was performed in a blinded fashion, using Volocity® software
(PerkinElmer, USA).
2.5. Flow cytometry (FACS)
Quantitative analyses of LVmacrophage number and phenotypewere
performed by FACS on tissue digests. Residual bloodwas ﬁrst rinsed from
the LV which was then dissected into infarcted and remote myocardium
for separate analysis. Samples were digested in a mixture of collagenase
IV, DNase and hyaluronidase at 37 °C for 30 min followed by trituration
andﬁltration through a 70 μmnylonmesh. Cell suspensionswerewashed
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and blocked with anti-CD16/CD32 antibodies prior to staining. Macro-
phages were identiﬁed as CD45+, lineage negative (CD19−, CD3−,
NK1.1−, Ly6G−), CD11b+F4/80+ cells and quantiﬁed for both Ly6C and
MRC1 (CD206) expression. 7-amino-actinomycinDdyewasused to iden-
tify dead cells (Supplementary Fig. 2).
FACS of leukocytes in male mice is described in Supplementary Ma-
terials. Fluorescence-minus-one (FMO) stained samples were used as
negative controls. Experiments were performed on a FACS CantoII® in-
strument (BD Biosciences, New Jersey). Data analysis was performed
with FlowJo software (Tree Star Inc., USA).
FACS was also performed on blood samples to study leukocyte and
monocyte subsets (see Supplementary Materials).
2.6. Statistics
Data are reported as mean ± SEM. Comparisons of groups were un-
dertaken by Student's t test or two-way ANOVA followed by
Bonferroni's post-test, as appropriate, using GraphPad Prism 5.00.
Kaplan–Meier survival analysis was performed over a 7-day period fol-
lowing MI. P b 0.05 was considered signiﬁcant.
3. Results
3.1. Effect on BMT on infarct size and remodelling post-MI
Female mice that had undergone BMT and matched control animals
(n = 10 per group) were subjected to left coronary ligation and then
followed up for 21 days. We used serial CMRI to assess the initial infarct
size, subsequent LV remodelling, contractile function and ﬁnal infarct
size. The two groups had similar LVESV, LVEDV and EF prior to MI
(Fig. 1A–C). The initial infarct size estimated by LGE on CMRI 3 days
post-MI was approximately 40% of the LV in both groups (Fig. 1E). In
line with this, LVESV, LVEDV and EF were similar in the control and
BMT groups at 3 days post-MI (Fig. 1A–C). By 7 and 21 days post-MI,
there was a progressive increase in LVEDV and LVESV and a decrease in
EF in the controlMI group, indicating adverse LV remodelling. In contrast,
the BMT MI group showed substantially lower increases in LVEDV and
LVESV at these time-points while EF was signiﬁcantly higher than in
the control group (Fig. 1A–C). The relative infarct area as a percentage
of the LV remained approximately 40% at 7 and 21 days in the control
group (Fig. 1F). However, the relative infarct area gradually decreased
at 7 and 21 days in the BMT group (Fig. 1F), indicating altered LV re-
modelling and/or scar properties. The wall thickness in the infarcted
region on CMRI at 21 days was signiﬁcantly higher in the BMT than
control group (Fig. 1D). LV mass measured post-mortem (21 days
post-MI) was signiﬁcantly higher in the control group than the BMT
group (113.5 ± 11.2 mg versus 74.3 ± 7.5 mg; p b 0.05). These results
indicate that the BMT group had signiﬁcantly less adverse remodelling
post-MI than the control group despite a similar initial infarct size.
We analysed survival over a 12 day period after MI in a cohort of fe-
male control and BMTmice. This showed signiﬁcantly higher survival in
the mice that had undergone BMT (Fig. 1G). We performed a similar
study in male C57BL/6 mice, which are known to have a higher rate of
infarct rupture andmortality post-MI [19], and again found signiﬁcantly
higher survival in the BMT group (Fig. 1H).
3.2. CMRI evidence of T2* signal voids in the infarcted area after BMT
T2*-weighted CMRI at 21 days in the BMT group showed signiﬁcant
signal voids in the infarcted tissue in the absence of contrast injection, a
Fig. 1. Functional and volumetric cardiac parameters afterMI in control andBMTmice. A–C: Ejection fraction (EF), left ventricle end diastolic volume (LVEDV) and left ventricle end systolic
volume (LVESV) assessed by CMRI. D: Wall thickness in the infarct region. E: Infarct size 3 days post-MI, evaluated by late Gadolinium enhancement (LGE). Representative images are
shown to the right. F: Infarct size at 10 and 21 days post-MI, calculated by a midline method. Representative images are shown to the right. G–H: Survival curves for female mice (n =
20/group) and male mice (n = 21 control, n = 9 BMT) subjected to MI. Bar graph data are mean ± SEM. *p b 0.05, **p b 0.01, ****p b 0.0001.
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ﬁnding that was never observed in the control MI group. Fig. 2A shows
representative apex-to-base short axis T2*-weighted images of control
and BMT mice 21 days after MI. The signal void in the BMT heart,
starting at the point of LAD ligature, continues in the following 2 slices
towards the apex, indicating the presence of a susceptibility source in
the infarcted tissue. Little or no signal void was detected in any of the
groups at 3 and 10 days.
During T2* acquisitions, a susceptibility source is characterised by
three main effects: (a) a negative signal area; (b) expansion of such
an area with increasing TE; (c) T2* values much lower than the sur-
rounding tissues. Fig. 2B demonstrates that when TE was increased
from 1 to 7 ms, the signal void area signiﬁcantly increased. The T2*
values related to these signal voids were 2.37± 0.30ms in the infarct
area of the BMT group while remote areas and myocardium in the
control group had a value of 13.45 ± 0.74 ms. In the absence of ad-
ministration of iron-based contrast agents, signal voids of this type
are most likely to be due to the presence of haemosiderin within
the infarct, as a breakdown product of haemoglobin or myoglobin
[20,21].
3.3. Histological ﬁndings
We undertook detailed histological comparison of the infarct region
in control and BMT groups 21 days after induction of MI (Fig. 3). The LV
wall at the infarcted sitewas thicker in the BMT compared to the control
group on sections stained for troponin I. LVwall thickness in the infarct-
ed area was greater in the BMT animals compared to controls (236 ±
22 μm vs. 327 ± 36 μm; p b 0.01; Fig. 3B). Though MRI and histology
gave a similar trend, absolute values were different because of the
post mortem processing of the sample.
At high power, there was a small endocardial rim of cardiomyocytes
evident on H&E and troponin staining in the control group and only the
very occasional cardiomyocyte within the scar (Fig. 4A, B). The scar tis-
sue comprised predominantly ﬁbroblasts (identiﬁed by their elongated
nuclei) and collagen, with occasional areas of inﬂammatory cells but no
vascular structures (Fig. 4C, D). The BMT infarct showed substantially
more cardiomyocytes, present in the subendocardium, subepicardium
and within the infarct itself. These myocytes were of similar size to
those in the remote myocardium consistent with them being surviving
myocytes. There were also signiﬁcantly more inﬂammatory cells, most
of them being macrophages, based on their morphology. CD45 immu-
nostaining conﬁrmed the higher level of mononuclear cell inﬁltration
in the infarct area of the BMT group (Fig. 4E, F). Interestingly, most of
themacrophages had a spindle-shaped dendritic morphology, a charac-
teristic of alternatively activated (or M2) macrophages [22,23].
In viewof the signal voids observed on CMRI, we performed Prussian
blue-staining to look for iron (haemosiderin) deposition. The lowmag-
niﬁcation images revealed extensive iron deposition within the infarct-
ed area in the BMT groupwhereasminimal stainingwas observed in the
control group (Fig. 3A). At highmagniﬁcation, the Prussian Blue staining
was found to be predominantly intracellular within the spindle-shaped
macrophages, which we consider is most likely related to the phagocy-
tosis of dead haem-containing cells such as cardiomyocytes or erythro-
cytes and the breakdown of myoglobin or haemoglobin (Fig. 4G, H).
Interestingly, CD163-positive macrophages (which have been implicat-
ed in the clearance of haemoglobin/haptoglobin complexes)weremore
abundant in the BMT than control group (Fig. 4I, J).
Infarcts in the BMT group also contained many irregular vascular
structures typical of granulation tissue, which were not observed in
the control infarcts (Fig. 4K–O). Positive staining for isolectin B4 and
sm22α in the infarcts of the BMT group conﬁrmed the presence of ves-
sels and indicated that they mostly had a smooth muscle component.
The overall histological structure of the remote myocardium was
similar in the control and BMT groups. However, the level of interstitial
ﬁbrosiswas signiﬁcantly higher in the control than theBMTgroup (Sup-
plementary Fig. 3).
Taken together, these results indicate that LV wall in the infarct re-
gion in the BMT group is thicker than the control group, with more
Fig. 2. Representative images of T2* signal voids observed on CMRI performed 21days post-MI. A: Apex to base short axis CMR images for control and BMTmice 21 days post-MI. There are
pronounced signal voids co-localisedwith the infarct region in the BMTmouse heart but no voids are seen in the control heart. B: T2* effects were studied by imaging themyocardium at
multiple echo times (TE). The T2* of signal void areas was signiﬁcantly lower than that of the control infarct region. Intramyocardial signal voids, caused by iron susceptibility effects, rep-
resent the presence of haem. Bar graph data are mean ± SEM. ***p b 0.001.
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surviving cardiomyocytes, more inﬂammatory cells (including many
with haemosiderin within them) and frequent vascular structures.
3.4. BMT increases myocardial macrophage inﬁltration even before MI
Tomore carefully characterise and quantify the inﬂammatory cell in-
ﬁltrate, we analysed the macrophage population in myocardial tissue
digests by ﬂow cytometry. In a sub-group of mice, using the CD45.1/
CD45.2 chimaera system that exploits the different allelic forms of the
pan-leukocyte marker CD45, we were able to distinguish between
donor (CD45.1) and host-derived cells (CD45.2) after irradiation and
BMT. This analysis showed that BMT results in replacement of N92% of
the host cardiac macrophage population by donor cells and N93%
bloodmonocytes (Supplementary Fig. 4). The overall number of neutro-
phils, monocytes, and T and B lymphocytes were similar in animals that
had undergone BMT and controls (Supplementary Table 1).
Prior toMI, the total number of leukocytes (CD45+) in the heartwas
3-fold higher in the BMT group compared to control (Fig. 5A). The num-
ber of CD11b+/F4/80+ macrophages per mg of tissue was signiﬁcantly
higher in the BMT group and included both classically activated (M1)
Ly6chi cells and alternatively activated (M2) MRC1+ cells (Fig. 5B–D).
However, the proportion of alternatively activatedmacrophages (i.e. ei-
ther Ly6c− cells or MRC1+ cells) relative to total macrophageswas sub-
stantially higher in the BMT than control group (Fig. 5E–H). This is
supported by the observation in male mice that BMT hearts contain a
signiﬁcantly greater proportion of Mac2-immunoreactive macrophages
(Supplementary Fig. 5A) and also of YM-1 positive M2-like macro-
phages (Supplementary Fig. 5B) than non-irradiated controls.
We next analysed circulating blood monocyte subsets in mice that
had undergone BMT as compared to controlmice. This revealed a signif-
icant increase in Ly6c− and MRC1+ cells as a proportion of total mono-
cytes in the BMT compared to control group (Supplementary Fig. 6). To
assess whether the potential for polarisation into M1 versus M2-type
macrophages is altered after BMT, we studied bone marrow-derived
macrophages (BMDMs) from the BMT and control groups. Analysis of
in vitro polarisation into M1 or M2 phenotypes revealed that there
was no difference between the groups (Supplementary Fig. 7). We
assessed if the myocardial vascular bed properties were altered by
BMT Supplementary Fig. 8). There was no difference in capillary density
between the BMT and control groups. However, myocardial vessels had
enhanced endothelial VCAM-1 staining in the BMT group, suggestive of
endothelial activation.
Taken together, these results indicate that BMT results in an increase
in myocardial macrophages, especially alternatively activated macro-
phages, which may be related both to an increase in circulating
Ly6c−/MRC1+ cells and to myocardial endothelial activation.
3.5. Increased myocardial macrophage inﬁltration after BMT and MI
Fig. 6 shows the characterisation of cells within the myocardium in
the acute inﬂammatory phase 4 days post-MI. As expected, there was
a substantial increase in total leukocytes andmacrophages in the infarct
region of both groups of animals (Fig. 6A, B). However, the extent of in-
crease afterMIwasmuch higher in the BMT group, so that the cell num-
ber was 5–6 fold higher than the control group. Furthermore, there was
a signiﬁcantmacrophage inﬁltration in the remote non-infarcted area in
the BMT group. Overall numbers of Ly6c− andMRC1+ cells were signif-
icantly greater in the BMT compared to control group, both in the in-
farcted and remote areas (Fig. 6C–F).
4. Discussion
The main ﬁnding of this study is that mice that have previously un-
dergone BMT display a signiﬁcantly altered structural and functional
cardiac response to acute permanent coronary artery occlusion, with
less thinning of thewall in the infarct region, reduced ventricular dilata-
tion and better preserved contractile function thanmatched naive mice
also subjected to acute MI. The enhanced recovery from acute MI in
mice that have undergone BMT is associated with a signiﬁcantly altered
myocardial macrophage polarisation phenotype, comprising an in-
creased number of alternatively activated (M2) macrophages in the
myocardium.
Whilst undertaking a serial CMRI study to assess post-MI remodel-
ling in mice that had undergone BMT, we noticed that the BMT group
did not develop the same degree of LV dilatation and adverse remodel-
ling as observed in control animals without BMT. The difference be-
tween groups became apparent from 1 to 3 weeks after MI whereas
there were no signiﬁcant differences in cardiac volumes and function
early (3 days) after MI, consistent with a similar initial insult. Indeed,
the initial infarct size estimated by LGE at 3 days post-MI was similar
in the 2 groups. Serial CMRI showed that the LVwall in the infarct region
did not thin to a similar extent in the BMT group as in control mice. Fur-
thermore, animals that had undergone prior BMT showed higher sur-
vival after MI than control mice, both in females and in a model of
more severe MI in male mice where there is a signiﬁcant (around
25%) incidence of cardiac rupture.
Detailed histological analysis conﬁrmed the presence of a thicker LV
wall in the infarct region in the BMT group compared to the control
group. It was notable that the infarcts in the BMT group hadmore layers
of cardiomyocytes in the subendocardial and subepicardial regions than
in control infarcts. Because the morphology and size of these
cardiomyocytes was similar to that of myocytes in the remote non-
infarcted regions, this ﬁndingmay reﬂect a higher proportion of surviv-
ing cardiomyocytes in the BMT group. However, we did not undertake a
Fig. 3. Infarct thickness is increased in the BMT group. A: Representative transverse cross-
sections of the whole heart from control and BMT mice 21 days post-MI. Sections are
stained with haematoxylin and eosin (H&E), Picrosirius red and Prussian blue. The infarct
region (bright red staining with Picrosirius red) is thicker and has robust Prussian blue
staining in the BMT heart. B: Transverse cross-sections stained with an anti-troponin I an-
tibody (red) for cardiomyocytes. The histogram shows the thickness of the LV in the in-
farcted region, measured at high magniﬁcation. Data are mean ± SEM from 5 hearts per
group. **p b 0.01. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
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detailed analysis of cardiomyocyte numbers in these hearts. The alter-
native possibility that there might have been cardiomyocyte regenera-
tion within the infarct appears unlikely because this is reported to be
associated with smaller cardiomyocytes over a 3 week post-MI period
[24]. The overall ﬁbrous tissue within the infarcts appeared similar in
the BMT and control groups. The increased LV wall thickness in the in-
farct region of the BMT group, potentially related to an increased num-
ber of cardiomyocytes, is highly likely to be the explanation for the
reduced degree of post-MI adverse remodelling, as a consequence of
lower wall stress in the infarct region (regardless of whether these
myocytes perform useful contractile work) [25].
Histological analysis also revealed that the infarcts of the BMT group
contained substantially more inﬂammatory cells than control infarcts.
We noted the presence of many irregular vascular structures in the in-
farcts of the BMT group. These neovessels usually had a smooth muscle
coating, suggesting some degree of maturation. The pattern of inﬂam-
matory cell inﬁltration after acute MI in the mouse has been well docu-
mented [26]. It is well established that different subsets of monocytes/
macrophages are present in the infarct; Ly6chi cells are the predominant
subtype during the ﬁrst 1–2 days, after which time Ly6clow
macrophages begin to predominate [26–28]. The Ly6chi macrophages,
also known as classically activated macrophages, typically produce
pro-inﬂammatory cytokines, generate reactive oxygen species (ROS)
and have a high scavenging activity. Conversely, the Ly6clow
(alternatively activated or M2) macrophages secrete high levels of
anti-inﬂammatory cytokines (e.g. interleukin-10),modulate the inﬂam-
matory response, are pro-angiogenic, and are thought participate in tis-
sue repair [29]. Mannose receptor MRC1 (CD206) and Ym-1 expression
also identiﬁes theM2 subset [30–32]. Histologically, themacrophages in
the infarcts of BMTmiceweremostly spindle-shaped cells suggestive of
M2macrophages [22,23].We therefore investigated thepattern ofmyo-
cardialmacrophage inﬁltration in the early phase ofMI based on the ex-
pression of Ly6c and MRC1 [30,31,33]. Quantitative ﬂow cytometric
analysis of infarct and non-infarct regions revealed a substantially
higher number of M2 macrophages (Ly6c− and MRC1+) in the infarcts
of the BMTgroup early afterMI than in controlmice, conﬁrming the his-
tological ﬁndings.
An additional striking observation at CMRI in the BMT/MI groupwas
the presence of T2* intramyocardial signal voids, which is strongly sug-
gestive of the presence of highly ferromagnetic haemosiderin (or ferri-
tin). Histological analysis by Prussian blue staining conﬁrmed the
presence of substantially more iron in the infarcts of the BMT group
and demonstrated that the stainingwas predominantly intracellular. In-
terestingly, the intracellular iron was sequestered predominantly in the
spindle-shapedmacrophages. Themost likely sources of iron in the set-
ting ofMI are either frommyoglobin fromdead cardiomyocytes or from
haemoglobin derived from extravasated blood. Although intra-infarct
haemorrhage is more likely to occur in reperfused infarcts than with
Fig. 4. Representative high magniﬁcation images showing increased inﬂammatory cells and neovessels in BMT compared to control infarcts. A, B: Troponin I staining (red) shows
cardiomyocytes in both the epicardial and endocardial regions of the infarct in the BMT group whereas the control infarct only has a thin layer of subendocardial cardiomyocytes. Nuclei
are stainedwith Dapi (blue). C, D: H&E staining reveals an accumulation of ﬁbroblasts andmononuclear cells in the infarct. Arrows indicate spindle-shapedM2macrophages. E, F: Immu-
nostaining of CD45 positive cells (leukocytes, brown cytosolic staining) shows signiﬁcantly more cells in the BMT group. G, H: Prussian blue staining shows intracellular hemosiderin (ar-
rows) in the BMT group. I, J: Increased CD163-positivemacrophages are observed in the BMT infarct. K–N: Irregular vascular structures are frequently observed in the BMT infarct, labelled
for endothelial cellswith Isolectin B4 (K, L— green) or for smoothmusclewith anti-sm22α (M, N— green). Rhodamine-conjugatedwheat germagglutinin (WGA, red)was used to outline
cellmembranes. (For interpretation of the references to colour in thisﬁgure legend, the reader is referred to theweb version of this article.) O:Quantiﬁcation of the areawithin infarcts that
was occupied by vascular structures. Sections stained for Isolectin B4 andWGAwere observed at 40×magniﬁcation. Data are mean ± SEM from 3 random ﬁelds per infarct and 5 hearts
per group. ****p ≤ 0.0001.
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permanent occlusion [20], it is also possible that the neovessels within
the infarct in the BMT group might be leaky and might promote some
extravasation of blood.
The presence of increased M2 macrophages in the infarct region of
BMT mice may be central to the improved post-MI recovery that was
observed. The increase in vascularity of the infarct in BMTmice is likely
to be related to the pro-angiogenic properties of M2 macrophages,
which have been implicated in vascular morphogenesis during devel-
opment and in post-natal physiological and pathological tissue remod-
elling [34]. It is possible that themacrophageswithin the infarcts of BMT
mice may mediate more efﬁcient degradation of dead cardiomyocytes
than in control infarcts and may have other properties (e.g. antioxidant
actions) that secondarily promote the survival of viable cardiomyocytes
within the infarct. A more efﬁcient clearing of dead cardiomyocytes
would be consistent with the ﬁnding of signiﬁcant iron deposits within
themacrophages. The increased vascularity of the infarct could promote
cardiomyocyte survival, although this seems less likely in view of the
immaturemorphology of the vessels [21,27,29–31,33,35]. It is also pos-
sible that the effects of irradiation on other resident myocardial cells
(e.g. ﬁbroblasts, vascular cells or cardiomyocytes) could contribute to
the reduced adverse post-MI remodelling in the BMT group.
An increased number of alternatively activated macrophages were
present in the hearts of the BMT group not only after infarction but
also before MI. Furthermore, we found a higher number of circulating
Ly6c−monocytes in the blood following BMT. In addition, therewas ev-
idence of endothelial activation in the myocardial vessels of mice after
BMT, as assessed by VCAM-1 staining. These ﬁndings suggest that the
process of BMT per semay increase both themobilisation of monocytes
into the blood and their recruitment into the myocardium, with a pre-
dominance of alternatively activated cells. We found no evidence of in-
trinsic differences between the BMT and control groups in the in vitro
potential to polarise into M1 or M2-type macrophages. Polarisation of
macrophages to an M2 phenotype within themyocardiummay be pro-
moted by the efferocytosis bymacrophages of dead/dying host cells that
have been irreparably damaged by irradiation [36,37]. The presence of
these cells in the myocardium even before induction of MI, in addition
to the higher inﬂux after coronary occlusion, may facilitate the im-
proved recovery after infarction. To our knowledge, these quite substan-
tial effects have not previously been noted and therefore have not been
taken into account in studies of inﬂammatory mechanisms in which
BMT was employed as an experimental strategy.
Macrophages express CD91 and CD163 which are speciﬁc receptors
for haem and haemoglobin complexes [18]. Recently, a new sub-
population of MRC1+ macrophages that express both CD91 and CD163
– termed Mhem cells –was described in human atherosclerotic plaques
[38,39]. It was proposed that haem derived from intraplaque haemor-
rhage or from direct erythrophagocytosis drives this subset of macro-
phages, which may have atheroprotective antioxidant properties
mediated at least in part through the induction of haem oxygenase-1
[40,41]. In this context, it is of interest that haem-containing macro-
phages were a very prominent feature of the infarcts in BMT mice. It is
possible that the internalisation of haem (derived either frommyoglobin
or from extravasated blood) may drive the polarisation of macrophages
into a Mhem-like phenotype. Although possible effects of Mhemmacro-
phages in the heart have not been reported, it is well established that ac-
tivation of the haem oxygenase-1 pathways is protective in the setting of
Fig. 5. BMTpromotes inﬁltration ofmonocytes/macrophages into themyocardiumeven beforeMI. Flow cytometric analyses of inﬂammatory cells in LVmyocardial digests of hearts from con-
trol and BMTmice before induction of MI. A–D: Quantiﬁcation of total leukocytes (A), macrophages (B), and macrophage subsets according to expression of Ly6c (C) or MRC1 (D). E, F: Rep-
resentative pseudocolour ﬂow cytometry plots showing macrophage distribution by Ly6c and MRC1. G, H: Ly6c− and MRC1+ macrophages as a proportion of total macrophages in the
myocardium. Results are mean ± SEM; n = 5 per group. *p b 0.05, **p b 0.01, ***p b 0.001, ****p b 0.0001.
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post-MI remodelling [42,43]. Therefore, Mhem-like macrophages could
contribute to the protective anti-remodelling effects observed in the
present study, a possibility that merits further study.
Based on the ﬁndings of the current study, we propose the following
scheme to explain the anti-remodelling effects observed after BMT. The
process of BMT enhances the mobilisation of monocytes into the blood,
their recruitment to themyocardium and/or polarisation to anM2 phe-
notype, possibly enhanced by the efferocytosis of dying cells. Following
coronary occlusion, there is an increased inﬂux of cells into the infarct
and the predominance of M2macrophages facilitates more efﬁcient re-
moval of necrotic cells and tissue and the development of neovessels.
Haem derived from cardiomyocyte myoglobin as well as extravasated
blood from leaky neovessels may induce the further differentiation of
M2 macrophages into a Mhem-like phenotype, which may further en-
hance tissue repair and cardiomyocyte survival. The overall preserva-
tion of ventricular function relates to the presence of a thicker LV wall
in the infarct region. However, other effects of radiation on resident car-
diac cells could also contribute to the observed reduction in adverse
post-MI LV remodelling. The current study highlights the necessity to
more carefully interpret the results of experimental studies in which
BMT is employed as a tool to distinguish between the effects of BM-
derived cells and other cell types.
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